Stock Events

Stock Events

Precipio 

$25.14
0
+$0+0% Today

Statistics

Day High
25.18
Day Low
25.14
52W High
-
52W Low
-
Volume
15
Avg. Volume
-
Mkt Cap
44.05M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

2AprExpected
Q3 2025
Next
-0.05
0.28
0.62
0.95
Expected EPS
N/A
Actual EPS
N/A

Financials

-23.15%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
37.06MRevenue
-8.58MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PRPO.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap11.72B
Guardant Health offers liquid biopsy tests similar to Precipio's diagnostic solutions, competing in the cancer diagnostics market.
Exact Sciences
EXAS
Mkt Cap12.25B
Exact Sciences provides cancer screening and diagnostic tests, directly competing with Precipio's diagnostic services.
Fulgent Genetics
FLGT
Mkt Cap687.17M
Fulgent Genetics provides comprehensive genetic testing, competing with Precipio in the genomic diagnostics space.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific offers a wide range of diagnostics and research products, indirectly competing with Precipio's diagnostic services.
Illumina
ILMN
Mkt Cap18.99B
Illumina provides genomic sequencing services and solutions, competing in the genomics space against Precipio.
Qiagen NV
QGEN
Mkt Cap10.16B
Qiagen offers sample and assay technologies for molecular diagnostics, competing with Precipio in the diagnostics market.

About

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.
Show more...
CEO
ISIN
US74019L6020

Listings

XNAS
US
PRPO
BOATS
BOATS
PRPO.BOATS

0 Comments

Share your thoughts

FAQ

What is Precipio stock price today?▼
The current price of PRPO.BOATS is $25.14 USD — it has increased by +0% in the past 24 hours. Watch Precipio stock price performance more closely on the chart.
What is Precipio stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Precipio stocks are traded under the ticker PRPO.BOATS.
What is Precipio market cap?▼
Today Precipio has the market capitalization of 44.05M
When is the next Precipio earnings date?▼
Precipio is going to release the next earnings report on April 02, 2026.
What were Precipio earnings last quarter?▼
PRPO.BOATS earnings for the last quarter are -0.05 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Precipio revenue for the last year?▼
Precipio revenue for the last year amounts to 37.06M USD.
What is Precipio net income for the last year?▼
PRPO.BOATS net income for the last year is -8.58M USD.
When did Precipio complete a stock split?▼
Precipio has not had any recent stock splits.